Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 5521.28 | 258 / 258 | 100% | 57.49 | 230 / 230 |
esophagus | 100% | 6835.11 | 1445 / 1445 | 100% | 42.75 | 183 / 183 |
ovary | 100% | 5234.16 | 180 / 180 | 100% | 48.73 | 430 / 430 |
thymus | 100% | 5986.80 | 653 / 653 | 100% | 75.36 | 605 / 605 |
uterus | 100% | 6365.94 | 170 / 170 | 100% | 58.46 | 459 / 459 |
brain | 100% | 3950.40 | 2637 / 2642 | 100% | 46.28 | 705 / 705 |
kidney | 100% | 5492.31 | 89 / 89 | 100% | 58.04 | 899 / 901 |
pancreas | 100% | 2346.95 | 327 / 328 | 100% | 53.26 | 178 / 178 |
intestine | 100% | 6392.07 | 966 / 966 | 100% | 43.21 | 525 / 527 |
liver | 100% | 3091.50 | 225 / 226 | 100% | 41.02 | 406 / 406 |
prostate | 100% | 6518.58 | 245 / 245 | 99% | 59.56 | 499 / 502 |
skin | 100% | 5153.49 | 1809 / 1809 | 99% | 67.65 | 469 / 472 |
stomach | 100% | 4745.89 | 359 / 359 | 99% | 41.73 | 284 / 286 |
lung | 100% | 6595.45 | 578 / 578 | 99% | 52.16 | 1146 / 1155 |
breast | 100% | 5814.55 | 459 / 459 | 99% | 44.57 | 1109 / 1118 |
bladder | 100% | 7393.10 | 21 / 21 | 99% | 53.98 | 497 / 504 |
adipose | 100% | 5753.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8900.30 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 72.84 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 67.65 | 29 / 29 |
muscle | 100% | 7311.26 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5456.45 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 61.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 41.18 | 1 / 1 |
heart | 100% | 4761.86 | 859 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 5754.20 | 924 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0036151 | Biological process | phosphatidylcholine acyl-chain remodeling |
GO_0051247 | Biological process | positive regulation of protein metabolic process |
GO_0010887 | Biological process | negative regulation of cholesterol storage |
GO_0045723 | Biological process | positive regulation of fatty acid biosynthetic process |
GO_0090187 | Biological process | positive regulation of pancreatic juice secretion |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0060336 | Biological process | negative regulation of type II interferon-mediated signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0010867 | Biological process | positive regulation of triglyceride biosynthetic process |
GO_1903573 | Biological process | negative regulation of response to endoplasmic reticulum stress |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0032376 | Biological process | positive regulation of cholesterol transport |
GO_0048550 | Biological process | negative regulation of pinocytosis |
GO_0010745 | Biological process | negative regulation of macrophage derived foam cell differentiation |
GO_0090340 | Biological process | positive regulation of secretion of lysosomal enzymes |
GO_0032369 | Biological process | negative regulation of lipid transport |
GO_0090108 | Biological process | positive regulation of high-density lipoprotein particle assembly |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030154 | Biological process | cell differentiation |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0010875 | Biological process | positive regulation of cholesterol efflux |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_0051006 | Biological process | positive regulation of lipoprotein lipase activity |
GO_0010884 | Biological process | positive regulation of lipid storage |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0034191 | Molecular function | apolipoprotein A-I receptor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0046965 | Molecular function | nuclear retinoid X receptor binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0051117 | Molecular function | ATPase binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NR1H2 |
Protein name | Liver X nuclear receptor beta (Nuclear receptor subfamily 1, group H, member 2, isoform CRA_c) Nuclear receptor subfamily 1 group H member 2 NR1H2 protein Liver X receptor beta Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor NER) (Nuclear receptor subfamily 1 group H member 2) (Ubiquitously-expressed nuclear receptor) |
Synonyms | NER hCG_22944 UNR LXRB |
Description | FUNCTION: Nuclear receptor that exhibits a ligand-dependent transcriptional activation activity . Binds preferentially to double-stranded oligonucleotide direct repeats having the consensus half-site sequence 5'-AGGTCA-3' and 4-nt spacing (DR-4). Regulates cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR and LRP8; DLDLR and LRP8. Interplays functionally with RORA for the regulation of genes involved in liver metabolism (By similarity). Induces LPCAT3-dependent phospholipid remodeling in endoplasmic reticulum (ER) membranes of hepatocytes, driving SREBF1 processing and lipogenesis (By similarity). Via LPCAT3, triggers the incorporation of arachidonate into phosphatidylcholines of ER membranes, increasing membrane dynamics and enabling triacylglycerols transfer to nascent very low-density lipoprotein (VLDL) particles (By similarity). Via LPCAT3 also counteracts lipid-induced ER stress response and inflammation, likely by modulating SRC kinase membrane compartmentalization and limiting the synthesis of lipid inflammatory mediators (By similarity). Plays an anti-inflammatory role during the hepatic acute phase response by acting as a corepressor: inhibits the hepatic acute phase response by preventing dissociation of the N-Cor corepressor complex . . |
Accessions | M0QYE6 M0R3A7 ENST00000593532.5 ENST00000597130.5 ENST00000652203.1 [P55055-1] P55055 M0QZF5 M0R0K3 ENST00000599105.5 ENST00000600355.5 ENST00000411902.6 [P55055-2] ENST00000253727.10 [P55055-1] B6ZGS7 ENST00000598168.5 F1D8P7 ENST00000597157.1 ENST00000597790.5 M0R229 M0R2F9 M0R1V8 ENST00000593926.5 [P55055-1] Q6IBU6 |